My right hon. Friend is being generous with his time. May I elaborate a little more on that specific point to give an indication to the Minister of the specifics that might cause difficulty between different clinical commissioning group areas? In my experience, those who are allowed to have clinical access to a glucose monitoring device already need to have their blood sugar levels under control—in single digits, below nine. For many people, however, the monitoring device is the one thing that gives them the ability to get better control of their blood sugar glucose levels. Therefore, if they do not get access to it until they are under control, it does not have the immediate benefit to their lifestyles that it would if the regime were slightly more permissive in the allocation of the devices.